Tau-directed drug discovery for alzheimer's disease and related tauopathies: a focus on tau assembly inhibitors

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics

Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · see citing works

Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy

Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359 · see citing works

Drug-like properties and the causes of poor solubility and poor permeability

Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,776 · see citing works

Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17

Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498 · see citing works

Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease

Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492 · see citing works

Neurodegenerative Tauopathies

Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480 · see citing works

Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders

Ballatore, C., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2194 · Cited by 2,174 · see citing works

Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease.

Kosik, K. S., Joachim, C. L., & Selkoe, D. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.4044 · Cited by 1,462 · see citing works

A68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau

Lee, V. M.-Y., Balin, B. J., Otvos, L., & Trojanowski, J. Q. (1991) · Science · doi:10.1126/science.1899488 · Cited by 1,418 · cited 2× · see citing works

Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans

Goedert, M., Jakes, R., Spillantini, M. G., Hasegawa, M., Smith, M. J., & Crowther, R. A. (1996) · Nature · doi:10.1038/383550a0 · Cited by 1,036 · see citing works

Mutation-Specific Functional Impairments in Distinct Tau Isoforms of Hereditary FTDP-17

Hong, M. (1998) · Science · doi:10.1126/science.282.5395.1914 · Cited by 1,003 · see citing works

Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease

(1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00057-2 · Cited by 981 · see citing works

Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau.

Drechsel, D. N., Hyman, A. A., Cobb, M. H., & Kirschner, M. W. (1992) · Molecular Biology of the Cell · doi:10.1091/mbc.3.10.1141 · Cited by 971 · see citing works

Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization.

Goedert, M., & Jakes, R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07870.x · Cited by 929 · cited 1× · see citing works

Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin

Cleveland, D. W., Hwo, S.-Y., & Kirschner, M. W. (1977) · Journal of Molecular Biology · doi:10.1016/0022-2836(77)90213-3 · Cited by 915 · see citing works

Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding

Bramblett, G. T., Goedert, M., Jakes, R., Merrick, S. E., Trojanowski, J. Q., & Lee, V. M. Y. (1993) · Neuron · doi:10.1016/0896-6273(93)90057-x · Cited by 903 · see citing works

Alzheimer’s disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules

Alonso, A. D. C., Grundke-Iqbal, I., & Iqbal, K. (1996) · Nature Medicine · doi:10.1038/nm0796-783 · Cited by 859 · see citing works

Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.

(1997) · PubMed · Cited by 745 · see citing works

Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs

Forman, M. S., Trojanowski, J. Q., & Lee, V. M.-Y. (2004) · Nature Medicine · doi:10.1038/nm1113 · Cited by 715 · see citing works

The high-affinity HSP90–CHIP complex recognizes and selectively degrades phosphorylated tau client proteins

Dickey, C. A., Kamal, A., Lundgren, K., Klosak, N., Bailey, R. M., Dunmore, J., Ash, P., Shoraka, S., Zlatkovic, J., Eckman, C. B., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29715 · Cited by 642 · see citing works

Structure and novel exons of the human .tau. gene

Andreadis, A., Brown, W. M., & Kosik, K. S. (1992) · Biochemistry · doi:10.1021/bi00158a027 · Cited by 625 · see citing works

Age-Dependent Emergence and Progression of a Tauopathy in Transgenic Mice Overexpressing the Shortest Human Tau Isoform

Ishihara, T., Hong, M., Zhang, B., Nakagawa, Y., Lee, M. K., Trojanowski, J. Q., & Lee, V. M.-Y. (1999) · Neuron · doi:10.1016/s0896-6273(00)81127-7 · Cited by 564 · see citing works

Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines.

Wischik, C. M., Edwards, P. C., Lai, R. Y., Roth, M., & Harrington, C. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.11213 · Cited by 547 · see citing works

Inhibition of Heparin-induced Tau Filament Formation by Phenothiazines, Polyphenols, and Porphyrins

Taniguchi, S., Suzuki, N., Masuda, M., Hisanaga, S., Iwatsubo, T., Goedert, M., & Hasegawa, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408714200 · Cited by 540 · see citing works

Nerve growth factor-induced neurite outgrowth in PC12 cells involves the coordinate induction of microtubule assembly and assembly-promoting factors.

Drubin, D. G., Feinstein, S. C., Shooter, E. M., & Kirschner, M. W. (1985) · The Journal of Cell Biology · doi:10.1083/jcb.101.5.1799 · Cited by 510 · see citing works

Tau proteins with FTDP‐17 mutations have a reduced ability to promote microtubule assembly

Hasegawa, M., Smith, M. J., & Goedert, M. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01217-4 · Cited by 482 · see citing works

Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases

Mazanetz, M. P., & Fischer, P. M. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2111 · Cited by 459 · see citing works

Mutations causing neurodegenerative tauopathies

Goedert, M., & Jakes, R. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.08.007 · Cited by 438 · see citing works

Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau

Alonso, A. D. C., Grundke-Iqbal, I., Barra, H. S., & Iqbal, K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.1.298 · Cited by 437 · see citing works

Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model

Zhang, B., Maiti, A., Shively, S., Lakhani, F., McDonald-Jones, G., Bruce, J., Lee, E. B., Xie, S. X., Joyce, S., Li, C., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406361102 · Cited by 413 · see citing works

Presenilin: Running with Scissors in the Membrane

Selkoe, D. J., & Wolfe, M. S. (2007) · Cell · doi:10.1016/j.cell.2007.10.012 · Cited by 376 · see citing works

Polymerization of τ into Filaments in the Presence of Heparin: The Minimal Sequence Required for τ ‐ τ Interaction

Pérez, M., Valpuesta, J., Medina, M., de Garcini, E. M., & Ávila, J. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67031183.x · Cited by 355 · see citing works

Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease.

(1997) · Europe PMC (PubMed Central) · Cited by 354 · see citing works

Structure, Microtubule Interactions, and Paired Helical Filament Aggregation by Tau Mutants of Frontotemporal Dementias

Barghorn, S., Zheng‐Fischhöfer, Q., Ackmann, M., Biernat, J., von Bergen�, M., Mandelkow�, E., & Mandelkow�, E. (2000) · Biochemistry · doi:10.1021/bi000850r · Cited by 351 · see citing works

Inducible Expression of Tau Repeat Domain in Cell Models of Tauopathy

Khlistunova, I., Biernat, J., Wang, Y., Pickhardt, M., von Bergen�, M., Gažová, Z., Mandelkow�, E., & Mandelkow, E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507753200 · Cited by 350 · see citing works

Familial multiple system tauopathy with presenile dementia: A disease with abundant neuronal and glial tau filaments

Spillantini, M. G., Goedert, M., Crowther, R. A., Murrell, J. R., Farlow, M. R., & Ghetti, B. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4113 · Cited by 334 · see citing works

Anthraquinones Inhibit Tau Aggregation and Dissolve Alzheimer's Paired Helical Filaments in Vitro and in Cells

Pickhardt, M., Gažová, Z., von Bergen�, M., Khlistunova, I., Wang, Y., Hascher, A., Mandelkow, E., Biernat, J., & Mandelkow�, E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410984200 · Cited by 334 · see citing works

Fitting Neurological Protein Aggregation Kinetic Data via a 2-Step, Minimal/“Ockham's Razor” Model: The Finke−Watzky Mechanism of Nucleation Followed by Autocatalytic Surface Growth

Morris, A. M., Watzky, M. A., Agar, J. N., & Finke, R. G. (2008) · Biochemistry · doi:10.1021/bi701899y · Cited by 307 · see citing works

Tau filaments from human brain and from in vitro assembly of recombinant protein show cross-β structure

Berriman, J. A., Serpell, L. C., Oberg, K. A., Fink, A. L., Goedert, M., & Crowther, R. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530287100 · Cited by 288 · see citing works

Aggregate‐Prone Proteins Are Cleared from the Cytosol by Autophagy: Therapeutic Implications

Williams, A. J., Jahreiss, L., Sarkar, S., Saiki, S., Menzies, F. M., Ravikumar, B., & Rubinsztein, D. C. (2006) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(06)76003-3 · Cited by 284 · see citing works

Accelerated filament formation from tau protein with specific FTDP‐17 missense mutations

Nacharaju, P., Lewis, J. M., Easson, C., Yen, S. H., Hackett, J., Hutton, M., & Yen, S.-H. C. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00294-x · Cited by 283 · see citing works

Tau phosphorylation and aggregation in Alzheimer's disease pathology

Ávila, J. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.02.067 · Cited by 283 · see citing works

Autophagic-lysosomal perturbation enhances tau aggregation in transfectants with induced wild-type tau expression

Hamano, T., Gendron, T. F., Causevic, E., Yen, S., Lin, W., Isidoro, C., DeTure, M., & Ko, L. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06084.x · Cited by 283 · see citing works

Differential regulation of microtubule dynamics by three- and four-repeat tau: implications for the onset of neurodegenerative disease

Panda, D., Samuel, J. C., Massie, M., Feinstein, S. C., & Wilson, L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633508100 · Cited by 280 · see citing works

Template-assisted filament growth by parallel stacking of tau

Margittai, M., & Langen, R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401911101 · Cited by 276 · see citing works

Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies

Luo, W., Dou, F., Rodina, A., Chip, S., Kim, J., Zhao, Q., Moulick, K., Aguirre, J., Wu, N. F., Greengard, P., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701055104 · Cited by 274 · see citing works

Phosphorylation of tau proteins to a state like that in Alzheimer's brain is catalyzed by a calcium/calmodulin-dependent kinase and modulated by phospholipids.

Baudier, J., & Cole, R. D. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45420-8 · Cited by 263 · see citing works

Small-molecule aggregates inhibit amyloid polymerization

Feng, B. Y., Toyama, B. H., Wille, H., Colby, D. W., Collins, S. R., May, B. C. H., Prusiner, S. B., Weissman, J. S., & Shoichet, B. K. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.65 · Cited by 257 · see citing works

Cellular phosphorylation of tau by GSK-3β influences tau binding to microtubules and microtubule organisation

Wagner, U., Utton, M. A., Gallo, J., & Miller, C. C. J. (1996) · Journal of Cell Science · doi:10.1242/jcs.109.6.1537 · Cited by 255 · see citing works

Anionic Micelles and Vesicles Induce Tau Fibrillization in Vitro

Chirita, C. N., Necula, M., & Kuret, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301663200 · Cited by 244 · see citing works

Tau alteration and neuronal degeneration in tauopathies: mechanisms and models

Brandt, R., Hundelt, M., & Shahani, N. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.06.018 · Cited by 222 · see citing works

A Neuronal Microtubule-Interacting Agent, NAPVSIPQ, Reduces Tau Pathology and Enhances Cognitive Function in a Mouse Model of Alzheimer’s Disease

Matsuoka, Y., Jouroukhin, Y., Gray, A. J., Ma, L., Hirata‐Fukae, C., Li, H.-F., Feng, L., Lecanu, L., Walker, B. R., Planel, E., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.130526 · Cited by 213 · see citing works

Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation

Dayanandan, R., van Slegtenhorst, M., Mack, T. G. A., Ko, L., Yen, S. H., Leroy, K., Brion, J., Anderton, B. H., Hutton, M. L., & Lovestone, S. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00222-7 · Cited by 210 · see citing works

Alzheimer-like Changes in Microtubule-associated Protein Tau Induced by Sulfated Glycosaminoglycans

Hasegawa, M., Crowther, R. A., Jakes, R., & Goedert, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.52.33118 · Cited by 205 · see citing works

Molecular biology and genetics of Alzheimer's disease

George‐Hyslop, P. S., & Petit-Paitel, A. (2005) · Comptes Rendus Biologies · doi:10.1016/j.crvi.2004.10.013 · Cited by 204 · see citing works

Characterization of Two VQIXXK Motifs for Tau Fibrillization in Vitro

Li, W., & Lee, V. M. ‐. (2006) · Biochemistry · doi:10.1021/bi061422+ · Cited by 197 · see citing works

HSP induction mediates selective clearance of tau phosphorylated at proline-directed Ser/Thr sites but not KXGS (MARK) sites

Dickey, C. A., Dunmore, J., Lu, B., Wang, J., Lee, W. C., Kamal, A., Burrows, F., Eckman, C., Hutton, M., & Petrucelli, L. (2006) · The FASEB Journal · doi:10.1096/fj.05-5343fje · Cited by 160 · see citing works

Rhodanine‐Based Tau Aggregation Inhibitors in Cell Models of Tauopathy

Bulic, B., Pickhardt, M., Khlistunova, I., Biernat, J., Mandelkow, E., Mandelkow�, E., & Waldmann, H. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200704051 · Cited by 158 · see citing works

The neuropathological diagnosis of Alzheimer's disease: clinical-pathological studies.

Hyman, B. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00066-3 · Cited by 146 · see citing works

Selective Destruction of Stable Microtubules and Axons by Inhibitors of Protein Serine/Threonine Phosphatases in Cultured Human Neurons (NT2N Cells)

Merrick, S. E., Trojanowski, J. Q., & Lee, V. M.-Y. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-15-05726.1997 · Cited by 143 · see citing works

Tau Therapeutic Strategies for the Treatment of Alzheimers Disease

Churcher, I. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606776743057 · Cited by 142 · see citing works

In Vitro Polymerization of Tau Protein Monitored by Laser Light Scattering: Method and Application to the Study of FTDP-17 Mutants

Gamblin, T. C., King, M. E., Dawson, H. N., Vitek, M. P., Kuret, J., Berry, R. W., & Binder, L. I. (2000) · Biochemistry · doi:10.1021/bi000201f · Cited by 137 · see citing works

Pseudophosphorylation and Glycation of Tau Protein Enhance but Do Not Trigger Fibrillization in Vitro

Necula, M., & Kuret, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405527200 · Cited by 136 · see citing works

Transgenic animal models of tauopathies

Lee, V. M. ‐., Kenyon, T. K., & Trojanowski, J. Q. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.06.014 · Cited by 134 · see citing works

Tau gene mutations and their effects

Goedert, M. (2005) · Movement Disorders · doi:10.1002/mds.20539 · Cited by 134 · see citing works

Ockham’s Razor

Garrett, A. J. M. (1991) · Springer eBooks · doi:10.1007/978-94-011-3460-6_36 · Cited by 129 · see citing works

Nucleation-dependent Tau Filament Formation

Congdon, E. E., Kim, S., Bonchak, J., Songrug, T., Anastasios Matzavinos, A., & Kuret, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800247200 · Cited by 126 · see citing works

Evidence that Non-Fibrillar Tau Causes Pathology Linked to Neurodegeneration and Behavioral Impairments

Brunden, K. R., Trojanowski, J. Q., & Lee, V. M. ‐. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14406 · Cited by 125 · see citing works

Phenylthiazolyl-Hydrazide and Its Derivatives Are Potent Inhibitors of τ Aggregation and Toxicity in Vitro and in Cells

Pickhardt, M., Larbig, G., Khlistunova, I., Çoksezen, A., Meyer, B., Mandelkow, E., Schmidt, B., & Mandelkow�, E. (2007) · Biochemistry · doi:10.1021/bi700878g · Cited by 125 · see citing works

Therapeutic Strategies for Alzheimer’s Disease

Barten, D. M., & Albright, C. F. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8031-2 · Cited by 122 · see citing works

Modeling Tau Polymerization in Vitro: A Review and Synthesis

Gamblin, T. C., Berry, R. W., & Binder, L. I. (2003) · Biochemistry · doi:10.1021/bi035722s · Cited by 115 · see citing works

Ligand-Dependent Inhibition and Reversal of Tau Filament Formation

Chirita, C. N., Necula, M., & Kuret, J. (2004) · Biochemistry · doi:10.1021/bi036094h · Cited by 104 · see citing works

High throughput screening for small molecule inhibitors of heparin-induced tau fibril formation

Crowe, A., Ballatore, C., Hyde, E. G., Trojanowski, J. Q., & Lee, V. M. ‐. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.056 · Cited by 101 · see citing works

Identification of Aminothienopyridazine Inhibitors of Tau Assembly by Quantitative High-Throughput Screening

Crowe, A., Huang, W., Ballatore, C., Johnson, R. L., Hogan, A. L., Huang, R., Wichterman, J., McCoy, J. G., Huryn, D. M., Auld, D. S., et al. (2009) · Biochemistry · doi:10.1021/bi9006435 · Cited by 101 · see citing works

Cyanine Dye N744 Inhibits Tau Fibrillization by Blocking Filament Extension: Implications for the Treatment of Tauopathic Neurodegenerative Diseases

Necula, M., Chirita, C. N., & Kuret, J. (2005) · Biochemistry · doi:10.1021/bi050387o · Cited by 89 · see citing works

Screening for Inhibitors of Tau Protein Aggregation into Alzheimer Paired Helical Filaments: A Ligand Based Approach Results in Successful Scaffold Hopping

Larbig, G., Pickhardt, M., Lloyd, D. G., & Schmidt, B. (2007) · Current Alzheimer Research · doi:10.2174/156720507781077250 · Cited by 58 · see citing works

Potency of a tau fibrillization inhibitor is influenced by its aggregation state

Congdon, E. E., Necula, M., Blackstone, R. D., & Kuret, J. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.05.004 · Cited by 30 · see citing works

ACCELERATED FILAMENT FORMATION FROM TAU PROTEIN WITH SPECIFIC FTDP-17 MISSENSE MUTATIONS

Nacharaju, P., Lewis, J. M., Easson, C., Yen, S. H., Hackett, J., Hutton, M. L., & Yen, S. H. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199905000-00157 · Cited by 12 · see citing works

Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models

Silva, M. C., Ferguson, F. M., Cai, Q., Donovan, K. A., Nandi, G., Patnaik, D., Zhang, T., Huang, H.-T., Lucente, D. E., Dickerson, B. C., et al. (2019) · eLife · doi:10.7554/elife.45457 · Cited by 283 · see citing works

Corticobasal degeneration: a pathologically distinct 4R tauopathy

Kouri, N., Whitwell, J. L., Josephs, K. A., Rademakers, R., & Dickson, D. W. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.43 · Cited by 246 · see citing works

Identification of the Tau phosphorylation pattern that drives its aggregation

Despres, C., Byrne, C., Qi, H., Cantrelle, F., Huvent, I., Chambraud, B., Baulieu, É.-É., Jacquot, Y., Landrieu, I., Lippens, G. M., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1708448114 · Cited by 246 · see citing works

Soluble forms of tau are toxic in Alzheimer's disease

Kopeikina, K., Hyman, B., & Spires-Jones, T. (2012) · Translational Neuroscience · doi:10.2478/s13380-012-0032-y · Cited by 232 · see citing works

Natural products against Alzheimer's disease: Pharmaco-therapeutics and biotechnological interventions

Dey, A., Bhattacharya, R., Mukherjee, A., & Pandey, D. K. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.12.005 · Cited by 232 · see citing works

High-Throughput Screening Platforms in the Discovery of Novel Drugs for Neurodegenerative Diseases

Aldewachi, H. S., Al-Zidan, R. N., Conner, M. T., & Salman, M. M. (2021) · Bioengineering · doi:10.3390/bioengineering8020030 · Cited by 209 · see citing works

Clinical development of curcumin in neurodegenerative disease

Hu, S., Maiti, P., Ma, Q., Zuo, X., Jones, M. R., Cole, G. M., & Frautschy, S. A. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1044981 · Cited by 179 · see citing works

Precortical Phase of Alzheimer's Disease ( AD )‐Related Tau Cytoskeletal Pathology

Stratmann, K., Heinsen, H., Korf, H., Turco, D. D., Ghebremedhin, E., Seidel, K., Bouzrou, M., Grinberg, L. T., Böhl, J., Wharton, S. B., et al. (2015) · Brain Pathology · doi:10.1111/bpa.12289 · Cited by 174 · see citing works

Voluntary Running Attenuates Memory Loss, Decreases Neuropathological Changes and Induces Neurogenesis in a Mouse Model of A lzheimer's Disease

Tapia‐Rojas, C., Aránguiz, F. C., Varela‐Nallar, L., & Inestrosa, N. C. (2015) · Brain Pathology · doi:10.1111/bpa.12255 · Cited by 168 · see citing works

Prolonged tau clearance and stress vulnerability rescue by pharmacological activation of autophagy in tauopathy neurons

Silva, M. C., Nandi, G. A., Tentarelli, S., Gurrell, I. K., Jamier, T., Lucente, D., Dickerson, B. C., Brown, D. G., Brandon, N. J., & Haggarty, S. J. (2020) · Nature Communications · doi:10.1038/s41467-020-16984-1 · Cited by 157 · see citing works

Why Pleiotropic Interventions are Needed for Alzheimer's Disease

Frautschy, S. A., & Cole, G. M. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8137-1 · Cited by 147 · see citing works

Aminothienopyridazines and methylene blue affect Tau fibrillization via cysteine oxidation

Crowe, A., James, M. J., Lee, V. M.-Y., Smith, A. B., Trojanowski, J. Q., Ballatore, C., & Brunden, K. R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.436006 · Cited by 143 · see citing works

Paired Helical Filaments from Alzheimer Disease Brain Induce Intracellular Accumulation of Tau Protein in Aggresomes

Santa‐María, I., Varghese, M., Ksiȩżak-Reding, H., Dzhun, A., Wang, J., & Pasinetti, G. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.323279 · Cited by 140 · see citing works

Preventive methylene blue treatment preserves cognition in mice expressing full-length pro-aggregant human Tau

Hochgräfe, K., Sydow, A., Matenia, D., Cadinu, D., Könen, S., Petrova, O. M., Pickhardt, M., Goll, P., Morellini, F., Mandelkow�, E., et al. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0204-4 · Cited by 137 · see citing works

Developing therapeutic approaches to tau, selected kinases, and related neuronal protein targets

Lee, V. M.-Y., Brunden, K. R., Hutton, M., & Trojanowski, J. Q. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006437 · Cited by 122 · see citing works

Therapeutic strategies for the treatment of tauopathies: Hopes and challenges

Khanna, M. R., Kovalevich, J., Lee, V. M. ‐., Trojanowski, J. Q., & Brunden, K. R. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.06.006 · Cited by 112 · see citing works

Customized Intranasal Hydrogel Delivering Methylene Blue Ameliorates Cognitive Dysfunction against Alzheimer's Disease

Liu, Y., Tan, Y., Cheng, G., Ni, Y., Xie, A., Zhu, X., Yin, C., Zhang, Y., & Chen, T. (2024) · Advanced Materials · doi:10.1002/adma.202307081 · Cited by 108 · see citing works

Antioxidant Properties of Crocus Sativus L. and Its Constituents and Relevance to Neurodegenerative Diseases; Focus on Alzheimer’s and Parkinson’s Disease

Hatziagapiou, K., Kakouri, E., Lambrou, G. Ι., Bethanis, K., & Tarantilis, P. Α. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180321095705 · Cited by 106 · see citing works

Acyl-coenzyme A:cholesterol acyltransferase 1 blockage enhances autophagy in the neurons of triple transgenic Alzheimer's disease mouse and reduces human P301L-tau content at the presymptomatic stage

Shibuya, Y., Niu, Z., Bryleva, E. Y., Harris, B. T., Murphy, S. R., Kheirollah, A., Bowen, Z. D., Chang, C. C. Y., & Chang, T. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.04.002 · Cited by 87 · see citing works

Modulation of Tau Protein Fibrillization by Oleocanthal

Monti, M. C., Margarucci, L., Riccio, R., & Casapullo, A. (2012) · Journal of Natural Products · doi:10.1021/np300384h · Cited by 88 · see citing works

Tauopathies: Deciphering Disease Mechanisms to Develop Effective Therapies

Silva, M. C., & Haggarty, S. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238948 · Cited by 87 · see citing works

Mesenchymal stem cells rescue the Alzheimer's disease cell model from cell death induced by misfolded truncated tau

Žilka, N., Žilková, M., Kazmerova, Z., Šarišský, M., Cigánková, V., & Novák, M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.06.088 · Cited by 75 · see citing works

Protein Aggregation Landscape in Neurodegenerative Diseases: Clinical Relevance and Future Applications

Candelise, N., Scaricamazza, S., Salvatori, I., Ferri, A., Valle, C., Manganelli, V., Garofalo, T., Sorice, M., & Misasi, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116016 · Cited by 69 · see citing works

Tau-tubulin kinase

Ikezu, S., & Ikezu, T. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00033 · Cited by 69 · see citing works

Neuroactive Multifunctional Tacrine Congeners with Cholinesterase, Anti-Amyloid Aggregation and Neuroprotective Properties

Kožurková, M., Hamuľaková, S., Gažová, Z., Paulíková, H., & Kristián, P. (2011) · Pharmaceuticals · doi:10.3390/ph4020382 · Cited by 68 · see citing works

Purpurin modulates Tau-derived VQIVYK fibrillization and ameliorates Alzheimer’s disease-like symptoms in animal model

Viswanathan, G. K., Shwartz, D., Losev, Y., Arad, E., Shemesh, C., Pichinuk, E., Engel, H., Raveh, A., Jelinek, R., Cooper, I., et al. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03312-0 · Cited by 66 · see citing works

Tetrahydrohyperforin prevents cognitive deficit, Aβ deposition, tau phosphorylation and synaptotoxicity in the APPswe/PSEN1ΔE9 model of Alzheimer's disease: a possible effect on APP processing

Inestrosa, N. C., Tapia‐Rojas, C., Griffith, T. N., Carvajal, F. J., Benito, M. J., Rivera-Dictter, A., Alvarez, A. R., Serrano, F. G., Hancke, J. L., Burgos, P. V., et al. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.19 · Cited by 65 · see citing works

GSPE interferes with tau aggregation in vivo: implication for treating tauopathy

Santa‐María, I., Díaz-Ruiz, C., Ksiȩżak-Reding, H., Chen, A. P., Ho, L., Wang, J., & Pasinetti, G. M. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.09.027 · Cited by 63 · see citing works

Rescue of neurons from undergoing hallmark tau-induced Alzheimer's disease cell pathologies by the antimitotic drug paclitaxel

Shemesh, O. A., & Spira, M. E. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.03.008 · Cited by 62 · see citing works

Chronic traumatic encephalopathy and other neurodegenerative proteinopathies

Tartaglia, M. C., Hazrati, L., Davis, K. D., Green, R., Wennberg, R. A., Mikulis, D. J., Ezerins, L., Keightley, M., & Tator, C. H. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00030 · Cited by 58 · see citing works

Xanthoceraside attenuates tau hyperphosphorylation and cognitive deficits in intracerebroventricular-streptozotocin injected rats

Liu, P., Zou, L., Wang, L.-H., Jiao, Q., Chi, T., Ji, X., & Jin, G. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3240-4 · Cited by 55 · see citing works

Pharmacophore-based models for therapeutic drugs against phosphorylated tau in Alzheimer’s disease

Pradeepkiran, J. A., Reddy, A. P., & Reddy, P. H. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.11.005 · Cited by 52 · see citing works

Inhibitory effect of corcin on aggregation of 1N/4R human tau protein in vitro.

Karakani, A. M., Riazi, G. H., Ghaffari, S. M., Ahmadian, S., Mokhtari, F., Firuzi, M. J., & Bathaie, S. Z. (2015) · Europe PMC (PubMed Central) · Cited by 51 · see citing works

Puromycin-sensitive aminopeptidase (PSA/NPEPPS) impedes development of neuropathology in hPSA/TAUP301L double-transgenic mice

Kudo, L. C., Parfenova, L. V., Ren, G., Vi, N., Hui, M. P.-P., Ma, Z., Lau, K., Gray, M., Bardag‐Gorce, F., Wiedau‐Pazos, M., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr065 · Cited by 50 · see citing works

Discovery of Brain-Penetrant, Orally Bioavailable Aminothienopyridazine Inhibitors of Tau Aggregation

Ballatore, C., Brunden, K. R., Piscitelli, F., James, M. J., Crowe, A., Yao, Y., Hyde, E. G., Trojanowski, J. Q., Lee, V. M. ‐., & Smith, A. B. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100138f · Cited by 50 · see citing works

Tau‐Tubulin Kinase 1 Expression, Phosphorylation and Co‐Localization with Phospho‐ S er422 Tau in the A lzheimer's Disease Brain

Lund, H., Cowburn, R. F., Gustafsson, E., Strömberg, K., Svensson, A., Dahllund, L., Malinowsky, D., & Sunnemark, D. (2012) · Brain Pathology · doi:10.1111/bpa.12001 · Cited by 50 · see citing works

Molecular hairpin: a possible model for inhibition of tau aggregation by tannic acid.

Yao, J.-L., Gao, X., Sun, W.-L., Yao, T.-M., Shi, S., & Ji, L. (2013) · Biochemistry · doi:10.1021/bi400240c · Cited by 47 · see citing works

Induced Tauopathy in a Novel 3D-Culture Model Mediates Neurodegenerative Processes: A Real-Time Study on Biochips

Seidel, D., Krinke, D., Jahnke, H., Hirche, A., Kloß, D., Mack, T. G. A., Striggow, F., & Robitzki, A. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049150 · Cited by 46 · see citing works

Inhibitory RNA Aptamers of Tau Oligomerization and Their Neuroprotective Roles against Proteotoxic Stress

Kim, J. H., Kim, E.-K., Choi, W. H., Lee, J., Lee, J. H., Lee, H., Kim, D., Suh, Y. H., & Lee, M. J. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00165 · Cited by 45 · see citing works

Advances in tau-based drug discovery

Noble, W. J., Pooler, A. M., & Hanger, D. P. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.586690 · Cited by 44 · see citing works

Modulation of Protein-Protein Interactions as a Therapeutic Strategy for the Treatment of Neurodegenerative Tauopathies

Ballatore, C., Brunden, K. R., Trojanowski, J. Q., Lee, V. M. Y., Smith, A. B., & Huryn, D. M. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611794072605 · Cited by 44 · see citing works

The structure and phase of tau: from monomer to amyloid filament

Zeng, Y., Yang, J., Zhang, B., Gao, M., Su, Z., & Huang, Y. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03681-x · Cited by 43 · see citing works

Integrating in vitro and in silico approaches to evaluate the “dual functionality” of palmatine chloride in inhibiting and disassembling Tau-derived VQIVYK peptide fibrils

Haj, E., Losev, Y., KrishnaKumar, V. G., Pichinuk, E., Engel, H., Raveh, A., Gazit, E., & Segal, D. (2018) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2018.04.001 · Cited by 41 · see citing works

Insights into the molecular interactions between aminopeptidase and amyloid beta peptide using molecular modeling techniques

Dhanavade, M. J., & Sonawane, K. D. (2014) · Amino Acids · doi:10.1007/s00726-014-1740-0 · Cited by 41 · see citing works

Inhibition of Tau Aggregation by Three Aspergillus nidulans Secondary Metabolites: 2,ω-Dihydroxyemodin, Asperthecin, and Asperbenzaldehyde

Paranjape, S., Chiang, Y., Sanchez, J. F., Entwistle, R., Wang, C. C. C., Oakley, B. R., & Gamblin, T. C. (2014) · Planta Medica · doi:10.1055/s-0033-1360180 · Cited by 37 · see citing works

NMR Meets Tau: Insights into Its Function and Pathology

Lippens, G. M., Landrieu, I., Smet‐Nocca, C., Huvent, I., Gandhi, N. S., Gigant, B., Despres, C., Qi, H., & Lopez, J. M. (2016) · Biomolecules · doi:10.3390/biom6020028 · Cited by 34 · see citing works

A novel role for retrograde transport of microtubules in the axon

Baas, P. W., & Mozgova, O. I. (2012) · Cytoskeleton · doi:10.1002/cm.21013 · Cited by 34 · see citing works

Tau protein aggregation: Key features to improve drug discovery screening

Giovannini, J., Smeralda, W., Jouanne, M., Santos, J. S. O., Catto, M., & Voisin‐Chiret, A. S. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.01.009 · Cited by 33 · see citing works

Frontiers in Alzheimer’s disease therapeutics

Stone, J. G., Casadesús, G., Rothenberg, K. G., Siedlak, S. L., Wang, X., Zhu, X., Perry, G. L., Castellani, R. J., & Smith, M. A. (2010) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622310382817 · Cited by 32 · see citing works

Age-related changes in hippocampal AD pathology, actin remodeling proteins and spatial memory behavior of male APP/PS1 mice

Sun, H., Liu, M., Sun, T., Chen, Y., Lan, Z., Lian, B., Zhao, C., Liu, Z., Zhang, J., & Liu, Y. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112182 · Cited by 31 · see citing works

Growth factor treatment to overcome Alzheimer's dysfunctional signaling

Lauzon, M.-A., Daviau, A., Marcos, B., & Faucheux, N. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.02.018 · Cited by 30 · see citing works

Alzheimer’s Disease: Characterization of the Brain Sites of the Initial Tau Cytoskeletal Pathology Will Improve the Success of Novel Immunological Anti-Tau Treatment Approaches

Rüb, U., Stratmann, K., Heinsen, H., Seidel, K., Bouzrou, M., & Korf, H. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161102 · Cited by 30 · see citing works

Aminothienopyridazine inhibitors of tau aggregation: Evaluation of structure–activity relationship leads to selection of candidates with desirable in vivo properties

Ballatore, C., Crowe, A., Piscitelli, F., James, M., Lou, K., Rossidivito, G., Yao, Y., Trojanowski, J. Q., Lee, V. M. ‐., Brunden, K. R., et al. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.05.027 · Cited by 29 · see citing works

Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-modifying Drugs

Froestl, W., Pfeifer, A., & Muhs, A. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121729 · Cited by 27 · see citing works

Repurposing nitrocatechols: 5-Nitro-α-cyanocarboxamide derivatives of caffeic acid and caffeic acid phenethyl ester effectively inhibit aggregation of tau-derived hexapeptide AcPHF6

Silva, T., Mohamed, T., Shakeri, A., Rao, P. P. N., Soares-da-Silva, P., Remião, F., & Borges, F. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.02.006 · Cited by 28 · see citing works

The Interplay of the Unfolded Protein Response in Neurodegenerative Diseases: A Therapeutic Role of Curcumin

Mukherjee, S., Mishra, A. K., Peer, G. D. G., Bagabir, S. A., Haque, S., Pandey, R. P., Raj, V. S., Jain, N. K., Pandey, A., & Kar, S. K. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.767493 · Cited by 27 · see citing works

The Structure Biology of Tau and Clue for Aggregation Inhibitor Design

Wang, D., Huang, X., Yan, L., Zhou, L., Chang, Y., Wu, J., Su, Z., & Huang, Y. (2021) · The Protein Journal · doi:10.1007/s10930-021-10017-6 · Cited by 26 · see citing works

Astroglial contribution to tau-dependent neurodegeneration

Sidoryk‐Wȩgrzynowicz, M., & Strużyńska, L. (2019) · Biochemical Journal · doi:10.1042/bcj20190506 · Cited by 26 · see citing works

Can MRI screen for CSF biomarkers in neurodegenerative disease?

McMillan, C. T., Avants, B., Irwin, D. J., Toledo, J. B., Wolk, D. A., Deerlin, V. M. V., Shaw, L. M. J., Trojanoswki, J. Q., & Grossman, M. (2012) · Neurology · doi:10.1212/wnl.0b013e31827b9147 · Cited by 24 · see citing works

Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease

Stancu, I., Ferraiolo, M., Terwel, D., & Dewachter, I. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_13 · Cited by 23 · see citing works

Ilex latifolia Prevents Amyloid β Protein (25–35)-Induced Memory Impairment by Inhibiting Apoptosis and Tau Phosphorylation in Mice

Kim, J. Y., Lee, H. K., Jang, J. Y., Yoo, J. K., & Seong, Y. H. (2015) · Journal of Medicinal Food · doi:10.1089/jmf.2015.3443 · Cited by 23 · see citing works

Formaldehyde‐Crosslinked Nontoxic Aβ Monomers to Form Toxic Aβ Dimers and Aggregates: Pathogenicity and Therapeutic Perspectives

Zhao, H., Huang, X., & Tong, Z. (2021) · ChemMedChem · doi:10.1002/cmdc.202100428 · Cited by 21 · see citing works

Targets, trials and tribulations in Alzheimer therapeutics

Gharat, R., Dixit, G., Khambete, M., & Prabhu, A. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176230 · Cited by 18 · see citing works

Rescue of tau-induced synaptic transmission pathology by paclitaxel

Erez, H., Shemesh, O. A., & Spira, M. E. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00034 · Cited by 19 · see citing works

Aspergillus in Biomedical Research

Mikawlrawng, K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-444-63505-1.00019-1 · Cited by 16 · see citing works

Pathogenic Tau Protein Species: Promising Therapeutic Targets for Ocular Neurodegenerative Diseases

Mishan, M. A., Kanavi, M. R., Shahpasand, K., & Ahmadieh, H. (2019) · Journal of Ophthalmic and Vision Research · doi:10.18502/jovr.v14i4.5459 · Cited by 18 · see citing works

Doubly Phosphorylated Peptide Vaccines to Protect Transgenic P301S Mice against Alzheimer’s Disease Like Tau Aggregation

Richter, M., Mewes, A., Fritsch, M., Krügel, U., Hoffmann, R., & Singer, D. L. (2014) · Vaccines · doi:10.3390/vaccines2030601 · Cited by 16 · see citing works

Deciphering the ‘Elixir of Life’: Dynamic Perspectives into the Allosteric Modulation of Mitochondrial ATP Synthase by J147, a Novel Drug in the Treatment of Alzheimer's Disease

Iwuchukwu, E. A., Olotu, F. A., Agoni, C., & Soliman, M. E. S. (2019) · Chemistry & Biodiversity · doi:10.1002/cbdv.201900085 · Cited by 15 · see citing works

α-Synuclein and tau, two targets for dementia

Silva, M., Caro, V., Guzmán, C., Perry, G. L., Areche, C., & Cornejo, A. (2020) · Studies in natural products chemistry · doi:10.1016/b978-0-12-819483-6.00001-1 · Cited by 15 · see citing works

Chaperone-Mediated Regulation of Tau Phase Separation, Fibrillation, and Toxicity

Mörman, C., Leppert, A., Pizzirusso, G., Zheng, Z., Sun, X., Kumar, R., Biverstål, H., Landreh, M., Johansson, J., Arroyo‐García, L. E., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c01369 · Cited by 13 · see citing works

Tau peptides and tau mutant protein aggregation inhibition by cationic polyethyleneimine and polyarginine

Nadimidla, K., Ismail, T., & Kanapathipillai, M. (2017) · Biopolymers · doi:10.1002/bip.23024 · Cited by 13 · see citing works

Detecting the Undetectable: Advances in Methods for Identifying Small Tau Aggregates in Neurodegenerative Diseases

Böken, D., Wu, Y., Zhang, Z.-W., & Klenerman, D. (2024) · ChemBioChem · doi:10.1002/cbic.202400877 · Cited by 10 · see citing works

Potential of Horse Apple Isoflavones in Targeting Inflammation and Tau Protein Fibrillization

Abourashed, E. A., Abraha, A., Khan, S. I., McCants, T., & Awan, S. (2015) · Natural Product Communications · doi:10.1177/1934578x1501000923 · Cited by 11 · see citing works

Exploring the Therapeutic Potential of Phytoconstituents for Addressing Neurodegenerative Disorders

Kamboj, S., Sharma, P., Kamboj, R., Kamboj, S., Hariom, Girija, Guarve, K., Dutt, R., Verma, I., Dua, K., et al. (2024) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/0118715249273015231225091339 · Cited by 10 · see citing works

Structural fingerprinting of pleiotropic flavonoids for multifaceted Alzheimer's disease

Punmiya, A., & Prabhu, A. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2023.105486 · Cited by 8 · see citing works

Targeted Degradation Technology Based on the Autophagy‐Lysosomal Pathway: A Promising Strategy for Treating Preeclampsia

Xiao, L., Mei, Z., Chen, J., Zhao, K., Zhang, H., Sharma, S., Liao, A., & Liu, C. (2025) · American Journal of Reproductive Immunology · doi:10.1111/aji.70066 · Cited by 7 · see citing works

X-Ray Structural Study of Amyloid-Like Fibrils of Tau Peptides Bound to Small-Molecule Ligands

Tayeb-Fligelman, E., & Landau, M. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6598-4_5 · Cited by 6 · see citing works

Effect of cellular polyanion mimetics on tau peptide aggregation

Ismail, T., & Kanapathipillai, M. (2018) · Journal of Peptide Science · doi:10.1002/psc.3125 · Cited by 6 · see citing works

Polyphenols and Alzheimer's Disease: Tau/polyphenol interactions investigated by NMR and molecular modelling

Guéroux, M., Laguerre, M. S., Szlosek‐Pinaud, M., Fouquet, É., & Pianet, I. (2012) · Nutrition and Aging · doi:10.3233/nua-130015 · Cited by 6 · see citing works

Targeting Axonal Transport: A New Therapeutic Avenue for ALS

Guo, W., Fumagalli, L., & Bosch, L. V. D. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.91963 · Cited by 5 · see citing works

The role of diet and antioxidants in the prevention of Alzheimer's disease

Dudkowiak, R., Gryglas‐Dworak, A., & Poniewierka, E. (2016) · Journal of Medical Science · doi:10.20883/jms.2016.144 · Cited by 5 · see citing works

What are the prospects of slowing the progression of Alzheimer's disease?

Palmer, A. M. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.09.009 · Cited by 4 · see citing works

Post-traumatic stress disorder: pathogenesis, epidemiological characteristics, animal models, and potential therapeutic strategies

Nguyen, F., & Shetty, A. K. (2026) · Military Medical Research · doi:10.1016/j.mmr.2026.100005 · Cited by 3 · see citing works

Microarray Gene and miRNA Expression Studies: Looking for New Therapeutic Targets for Frontotemporal Lobar Degeneration

Milanesi, E., & Pilotto, A. (2014) · Drug Development Research · doi:10.1002/ddr.21224 · Cited by 3 · see citing works

Stem Cell Approaches for Treatment of Neurodegenerative Diseases

Anand, S. (2014) · Clinical Pharmacology & Biopharmaceutics · doi:10.4172/2167-065x.1000126 · Cited by 3 · see citing works

From the gold-catalysed benzylation of arenes to the regio- and stereoselective synthesis of procyanidins dimers

Fabre, S., Guéroux, M., Nunes, E., Szlosek‐Pinaud, M., Pianet, I., & Fouquet, É. (2014) · Tetrahedron · doi:10.1016/j.tet.2014.11.011 · Cited by 3 · see citing works

Human chorionic gonadotropin decreases the phosphorylated tau protein level in streptozotocin-Alzheimeric male rats’ hippocampus

Bahlakeh, G., Jahanshahi, M., & Saeidi, M. (2018) · Folia Neuropathologica · doi:10.5114/fn.2018.76619 · Cited by 3 · see citing works

MAPT splicing modulators reduce 4R tau and rescue tauopathy phenotypes in human neurons and in a mouse model

Silva, M. C., Lindmeier, H., Pigini, P., Laughlin, J., Yu, Y., Morrill, C., Arnold, M. A., Barraza, S. J., Saadipour, K., Dieterich, M., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.ady6759 · Cited by 2 · see citing works

MAPT Splicing Modulators as a Therapeutic Strategy for TauopathiesPreprint

Silva, M. C., Lindmeier, H., Pigini, P., Laughlin, J., Yu, Y., Morrill, C., Arnold, M. A., Barraza, S. J., Saadipour, K., Dieterich, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.06.652428 · Cited by 1 · see citing works

Molekulare Grundlagen Tau-Protein-vermittelter Toxizität

Schneider, A., Falkai, P., & Papassotiropoulos, A. (2010) · Der Nervenarzt · doi:10.1007/s00115-010-3052-2

The Association Between Traumatic Brain Injury and Alzheimer's Disease: Mouse Models and Potential Mechanisms

Tran, H. (2011) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7gb223z

Mechanisms of palmitate induced amyloidogenesis in Alzheimer's Disease mediated by astrocytes

Liu, L. (2013) · doi:10.25335/hzqa-1c05

Design, synthesis and characterization of protein-protein interaction disruptors related to early amyloidogenic phenomena in Alzheimer's disease

Giovannini, J. (2021) · doi:10.70675/fb583cbdzb4cez4d61zbb7dz9ee01b9f6086

Development of Tau aggregation inhibitor in Alzheimer's disease

Tian-Ming, Y. (2011) · Applied Chemical Industry

Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies

Brunden, K. R., Trojanowski, J. Q., & Lee, V. M.-Y. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2959 · Cited by 440 · see citing works

S3‐03–05: Tau focused drug discovery for Alzheimer's disease and related tauopathies

Lee, V. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.389

S4‐02‐05: Tau focused drug discovery for Alzheimer's disease and related tauopathies

Lee, V. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.05.462

Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer's disease and related tauopathies

Moore, K. B. E., Hung, T.-J., & Fortin, J. S. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103487 · Cited by 86 · see citing works